Proactive Investors - Run By Investors For Investors

Aurora ‘takes a step forward’ in cannabis race by adding Peltz as advisor, says Melius Research

Melius Research analyst Rob Wertheimer says the addition of Peltz to the Aurora team is a ‘validation of the potential’ of cannabis industry
A cannabis cultivation farm
Headquartered in Edmonton, Alberta, Aurora boasts cannabis operations in 23 countries

Analysts at Melius Research said Aurora Cannabis Inc (NYSE:ACB) has taken "a step forward" in the cannabis race by appointing longtime activist investor Nelson Peltz as a strategic advisor.

The addition of Peltz to the Aurora team represents one of the largest endorsements of the nascent cannabis industry.

“Aurora’s announcement is both a validation of the potential in cannabis, and also adds expertise to what we see as a core need in the cannabis industry; building alliances and reach quickly,” wrote Melius Research analysts Rob Wertheimer and Marissa Schlueter in a report Wednesday.

READ: Melius Research initiates coverage of cannabis sector, says it will 'disrupt the beverage industry'

“For perspective, Nelson Peltz has been successful and exceptional investor in the consumer space both as a founder of Trian Partners and before, with deep ties to the consumer world,” they added.

Peltz, who founded and serves as CEO of New York-based Trian Partners, has over the decades commanded respect across Wall Street for his investing prowess. Trian’s portfolio and past investments include Dr Pepper Snapple Group, Wendys Co (NASDAQ:WEN), Kraft, Mondelez International (NASDAQ:MDLZ).

Peltz’s Triarc acquired Snapple from Quaker Oats back in 1997 and successfully revived the brand.

Melius recently initiated coverage of the cannabis sector with an Overweight rating on Aurora Cannabis and a C$17 price target. The firm said Aurora was its top pick citing upside from potential alliances, early scale in production and global reach.

“Our thesis includes the view that this race needs to be run quickly, and we favor Aurora shares for that reason,” wrote the analysts. “Legalization in the US will come, but will be a mixed blessing, as Canadian leaders need to turn that early position into something more meaningful before the wave of funding in the US comes and potentially swamps them.”

Budding market cannabis trends

The Melius report suggests the cannabis market can grow to US$100 billion in the Americas and Europe without further progress on legalization, which nonetheless remains likely.

That market estimate builds up from consumer surveys, pricing studies in legal and black markets, frequency of medical conditions addressable by cannabis across the US and EU member countries, and state-by-state and country-by-country legal frameworks.

Despite its not fully-legal status in the US more than 100 companies raised venture capital/private money in 2018 in the US, in more than 120 separate deals, according to Melius Research.

“For perspective, the number of companies raising private money in Canada was about 20, lower than the US by a typical margin despite a more favorable legal environment,” wrote the analysts.

Five years ago, about 40 US companies raised money for cannabis, and a couple of years before that, effectively zero.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter: @UttaraProactive

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full ACB profile View Profile

Aurora Cannabis Inc Timeline

Newswire
February 20 2019

Related Articles

medical cannabis concept
February 10 2019
AusCann is a fully integrated early-mover pharmaceutical cannabinoid company.
Cannabis leaf
November 19 2018
With the legalisation of recreational cannabis in Canada in October, and the US expected to follow suit, the company has its sights set on building up the very best in the industry
The Green Organic Dutchman windmill in a field
December 12 2018
TGOD has been building out its facilities in Ontario, Quebec, and Jamaica, expecting to reach combined production of 170,000 kilograms of cannabis around 2020
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use